Yüklüyor......
Current and emerging therapies for the treatment of myasthenia gravis
Myasthenia gravis (MG) is an autoimmmune disease in which autoantibodies to different antigens of the neuromuscular junction cause the typical weakness and fatigability. Treatment includes anticholinesterase drugs, immunosuppression, immunomodulation, and thymectomy. The autoimmune response is maint...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3083988/ https://ncbi.nlm.nih.gov/pubmed/21552317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S8915 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|